Redoxon by Albert Szent-Györgyi that isolated vitamin C from capsicum (peppers). After the sale of the Reichstein process patent to Hoffmann-La Roche, this process became the basis of the corporation's large-scale production of vitamin C. The present-day Redoxon tablets are compounded from ascorbic acid and sodium bicarbonate. When these are added to water, they react to produce sodium ascorbate, water and carbon dioxide, thus producing an effervescence. Some versions of Redoxon contain additional nutrients. Redoxon Redoxon was the brand name of the first artificially synthesized ascorbic acid (vitamin C). Redoxon was first marketed to the general public by Hoffman-La Roche in
Chemistry of ascorbic acid from animal adrenal glands. In 1932 Charles Glen King confirmed that it was indeed the antiscorbutic factor. In 1933, sugar chemist Walter Norman Haworth, working with samples of "hexuronic acid" that Szent-Györgyi had isolated from paprika and sent him in the previous year, deduced the correct structure and optical-isomeric nature of the compound, and in 1934 reported its first synthesis. In reference to the compound's antiscorbutic properties, Haworth and Szent-Györgyi proposed to rename it "a-scorbic acid" for the compound, and later specifically -ascorbic acid. Because of their work, in 1937 the Nobel Prizes for chemistry and medicine were awarded to